MedPath

A Comparative study on cauterization and internal medicine Arumuga Chenduram in management of Osteoarthritis

Phase 2
Conditions
Health Condition 1: M179- Osteoarthritis of knee, unspecified
Registration Number
CTRI/2019/05/019141
Lead Sponsor
Ayothidoss Pandithar hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients suffering from primary osteoarthritis of knee joint.Signs and symptoms of Pain, tenderness, stiffness and crepitus in kneejoint. Patients willing to undergo radiological investigation (X RAY KNEE JOINT) and Laboratory investigations. Patients willing to sign the informed consent stating that he/she will Conscientiously stick to the treatment during 48 days but can opt out of the trial of his/her own conscious discretion.Patients willing to take photograph before and after suttigai therapy

Exclusion Criteria

Recent history of trauma, fracture , surgery of affected knee joint. Presence of local infection or skin disease on the proposed site of Suttigai.H/o Cardiac diseases,Uncontrolled Diabetes mellitus,Uncontrolled Hypertension, Rheumatoid arthritis, Chronic kidney disease, Pregnancy and lactation, Secondary OA due to tuberculosis(TB), syphilis, AIDS, leprosy, Septic arthritis, Gonococcal arthritis,Psoriatic arthritis. Patient with any other serious systemic illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome of the study is relieving pain and it will be assessed by KOOS KNEE SURVEY -Knee injury and Osteoarthritis Outcome Score (KOOS)- Before and after the treatment <br/ ><br> <br/ ><br>Timepoint: 45 days <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Secondary outcome is assessed by comparing the clinical symptoms, clinical lab parameters and their quality of life before and after the treatment.Timepoint: 45 days
© Copyright 2025. All Rights Reserved by MedPath